IP Library › Patent Application 15001773
Patent Application
App. No. 15/001,773

TREATMENT OF MYELOSUPPRESSION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/001,773
Abstract

Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.

Claims (3)

1 . A method of attenuating a myelosuppressive side effect of a patient treatment regimen comprising:

adjunctively administering a therapeutically effective amount of a PF4-interacting heparinoid to the patient.

2 - 134 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2016
From: MARCUS, STEPHEN
To: PARINGENIX, INC.
Reel/Frame 037622/0069 →
CHANGE OF NAME Recorded Jan 29, 2016
From: PARINGENIX, INC.
To: CANTEX PHARMACEUTICALS, INC.
Reel/Frame 037652/0786 →